Cargando…
Microfilarial reduction following ProHeart® 6 and ProHeart® SR-12 treatment in dogs experimentally inoculated with a resistant isolate of Dirofilaria immitis
BACKGROUND: Emerging resistance of heartworms (Dirofilaria immitis) to macrocyclic lactone (ML) preventives is an increasing concern for veterinarians, pet owners and animal health companies that supply heartworm preventives, with recent reports of resistant isolates identified from the Mississippi...
Autores principales: | McTier, Tom L., Pullins, Aleah, Inskeep, Gregory A., Gagnon, Genevieve, Fan, Huihao, Schoell, Adam, Bidgood, Tara, Login, Joyce, Meeus, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688434/ https://www.ncbi.nlm.nih.gov/pubmed/29143650 http://dx.doi.org/10.1186/s13071-017-2430-z |
Ejemplares similares
-
Evaluation of the efficacy of ProHeart(®) 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs
por: Bowman, Dwight D., et al.
Publicado: (2017) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
por: McTier, Tom L., et al.
Publicado: (2019) -
Comparative preventive efficacy of ProHeart(®) 12, Heartgard(®) Plus and Interceptor(®) Plus against a macrocyclic lactone-resistant strain (JYD-34) of heartworm (Dirofilaria immitis) in dogs
por: McTier, Tom L., et al.
Publicado: (2021) -
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart(®) 12) in dogs
por: Krautmann, Matthew J., et al.
Publicado: (2019) -
The compliance and revenue benefits of ProHeart Vs monthly heartworm disease preventives in the US
por: Mwacalimba, Kennedy, et al.
Publicado: (2022)